PUBLIC HEALTH / RESEARCH PAPER
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
This study aimed to analyze the epidemiological trends and burden of osteoarthritis (OA) in the United States (U.S.) from 1990 to 2021 using data from the Global Burden of Disease (GBD) 2021 study, with a focus on sex, age, and geographic disparities.

Material and methods:
We used GBD 2021 data to examine OA incidence, prevalence, years lived with disability (YLDs), and age-standardized rates in the U.S., by gender, age group, and different states. Decomposition analysis was performed to assess contributions from population growth, aging, and epidemiological changes.

Results:
Between 1990 and 2021, OA incidence and prevalence in the U.S. increased by 80.3% and 90.3%, respectively. Females consistently exhibited a higher burden than males, with the highest incidence rate in the 55–59 age group. Geographically, California had the highest absolute case numbers, while Pennsylvania showed the highest age-standardized rates. Knee OA contributed most to disability, though hand OA dominated in the oldest populations. Decomposition analysis revealed that population growth (67.55%) was the primary driver of rising OA incidence.

Conclusions:
The OA burden in the U.S. has risen substantially over the past three decades, with marked disparities by sex, age, and region. Targeted public health strategies addressing prevention, early detection, and equitable healthcare access are urgently needed to mitigate this growing challenge.
REFERENCES (31)
1.
GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol 2023; 5: e508-22.
 
2.
Wang Z, Xiao Z, Sun C, Xu G, He J. Global, regional and national burden of osteoarthritis in 1990-2021: a systematic analysis of the global burden of disease study 2021. BMC Musculoskelet Disord 2024; 25: 1021.
 
3.
Wu R, Guo Y, Chen Y, Zhang J. Osteoarthritis burden and inequality from 1990 to 2021: a systematic analysis for the global burden of disease Study 2021. Sci Rep 2025; 15: 8305.
 
4.
WHO. https://www.who.int/news-room/.... Accessed 18, March 2025.
 
5.
Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine 2020; 29-30: 100587.
 
6.
Mathieson S, Ferreira G, Jones C, et al. The cost-effectiveness of guideline recommended treatments for osteoarthritis: a systematic review. Osteoarthritis Cartilage 2025; 33: 1274-92.
 
7.
Xie F, Thumboo J, Fong KY, et al. A study on indirect and intangible costs for patients with knee osteoarthritis in Singapore. Value Health 2008; 11 Suppl 1: S84-90.
 
8.
Dieleman JL, Baral R, Birger M, et al. US spending on personal health care and public health, 1996-2013. JAMA 2016; 316: 2627-46.
 
9.
GBD 2021 Gout Collaborators. Global, regional, and national burden of gout, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol 2024; 6: e749.
 
10.
The Osteoarthritis Action Alliance. OA Prevalence and Burden. https://oaaction.unc.edu/oa-mo.... Accessed 18, March 2025.
 
11.
Ma W, Chen H, Yuan Q, Chen X, Li H. Global, regional, and national epidemiology of osteoarthritis in working-age individuals: insights from the global burden of disease study 1990-2021. Sci Rep 2025; 15: 7907.
 
12.
Ren JL, Yang J, Hu W. The global burden of osteoarthritis knee: a secondary data analysis of a population-based study. Clin Rheumatol 2025; 44: 1769-810.
 
13.
Li HZ, Liang XZ, Sun YQ, Jia HF, Li JC, Li G. Global, regional, and national burdens of osteoarthritis from 1990 to 2021: findings from the 2021 global burden of disease study. Front Med 2024; 11: 1476853.
 
14.
Liu M, Jin F, Yao X, Zhu Z. Disease burden of osteoarthritis of the knee and hip due to a high body mass index in China and the USA: 1990-2019 findings from the global burden of disease study 2019. BMC Musculoskelet Disord 2022; 23: 63.
 
15.
GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2024; 403: 2133-61.
 
16.
The Global Health Observatory. Years of healthy life lost due to disability (YLD). https://www.who.int/data/gho/i.... Accessed 18, March 2025.
 
17.
Xu H, Xiao W, Ding C, et al. Global burden of osteoarthritis among postmenopausal women in 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021. BMJ Glob Health 2025; 10: e017198.
 
18.
Public Policy Institute of California. California’s population.https://www.ppic.org/publicati.... Accessed 18, March 2025.
 
19.
California Jobs First Council. California State Economic Blueprint. https://jobsfirst.ca.gov/wp-co.... Accessed 18, March 2025.
 
20.
Bill Johnston-Walsh. The Future is Now: Aging in Pennsylvania. https://www.cityandstatepa.com.... Accessed 18, March 2025.
 
21.
Healthcare Value Hub. Pennsylvania Residents Struggle to Afford High Healthcare Costs; Support a Range of Government Solutions Across Party Lines. https://healthcarevaluehub.org.... Accessed 18, March 2025.
 
22.
Chronic Disease Burden Report 2021. https://www.pa.gov/content/dam.... Accessed 18, March 2025.
 
23.
Hamood R, Tirosh M, Fallach N, Chodick G, Eisenberg E, Lubovsky O. Prevalence and incidence of osteoarthritis: a population-based retrospective cohort study. J Clin Med 2021; 10: 4282.
 
24.
Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA 2021; 325: 568-78.
 
25.
Pacheco Barzallo D, Schnyder A, Zanini C, Gemperli A. Gender differences in family caregiving. Do female caregivers do more or undertake different tasks?. BMC Health Serv Res 2024; 24: 730.
 
26.
Allen KD, Thoma LM, Golightly YM. Epidemiology of osteoarthritis. Osteoarthritis Cartilage 2022; 30: 184-95.
 
27.
Mei Y, Williams JS, Webb EK, Shea AK, MacDonald MJ, Al-Khazraji BK. Roles of hormone replacement therapy and menopause on osteoarthritis and cardiovascular disease outcomes: a narrative review. Front Rehabil Sci 2022; 3: 825147.
 
28.
Dennison EM. Osteoarthritis: the importance of hormonal status in midlife women. Maturitas 2022; 165: 8-11.
 
29.
Atasoy-Zeybek A, Showel KK, Nagelli CV, Westendorf JJ, Evans CH. The intersection of aging and estrogen in osteoarthritis. NPJ Womens Health 2025; 3: 15.
 
30.
Jordan JM, Helmick CG, Renner JB, et al. Prevalence of hip symptoms and radiographic and symptomatic hip osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project. J Rheumatol 2009; 36: 809-15.
 
31.
Ritchie ND, Baucom KJW, Sauder KA. Current perspectives on the impact of the national diabetes prevention program: building on successes and overcoming challenges. Diabetes Metab Syndr Obes 2020; 13: 2949-57.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top